Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertussis syrup for children with pertussis
ChiCTR2000029156Phase 4Not yet recruiting
- Sponsor
- Tianjin Second People's Hospital
- Start
- Feb 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Pertussis syrup in pertussis (2 arms), sponsored by Tianjin Second People's Hospital. Primary endpoint: 16S rRNA. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
Pertussis syrup
03
Conditions
pertussis
Beyond the preview
Go deeper on ChiCTR2000029156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029156.